Sarah Fritz, PhD
About Sarah Fritz, PhD
Sarah Fritz, PhD, is a postdoctoral researcher at the National Institutes of Health, focusing on the mechanism of PTBP1 control of nonsense-mediated mRNA decay. She has a background in biomedical sciences and biochemistry, having earned her PhD from The Ohio State University and previously worked at Pfizer and Antioch College.
Work at National Institutes of Health
Sarah Fritz has been a Postdoctoral Researcher at the National Institutes of Health (NIH) since 2016. Located in Bethesda, Maryland, her research focuses on the mechanisms of PTBP1 control of nonsense-mediated mRNA decay target selection. She works under the guidance of J. Robert Hogg, Ph.D., contributing to the understanding of RNA biology and its implications in cellular processes.
Education and Expertise
Sarah Fritz earned her Doctor of Philosophy (Ph.D.) in Biomedical Sciences from The Ohio State University, where she studied from 2010 to 2015. Prior to that, she obtained a Bachelor of Science (B.S.) in Biochemistry and Molecular Biology from Gettysburg College, completing her studies from 2006 to 2010. Her academic background has equipped her with expertise in protein synthesis, ribonucleoprotein biology, and RNA decay.
Background
Before her current role at the NIH, Sarah Fritz served as a Visiting Assistant Professor of Biology at Antioch College from 2015 to 2016. She also gained experience as a Summer Research Intern at Pfizer in 2009, where she worked for three months in Groton, Connecticut. Her diverse background in academia and industry has contributed to her research capabilities in the field of biomedical sciences.
Research Focus
Sarah Fritz specializes in the study of protein synthesis, ribonucleoprotein biology, and RNA decay. Her current research investigates the role of PTBP1 in nonsense-mediated mRNA decay target selection, which is crucial for understanding gene expression regulation and its impact on cellular function.